Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)

Journal of the American College of Cardiology

Volumn 58, Issue 5, 2011, Pages 493-501

  Camm, A John ^a   Breithardt, Günter ^b   Crijns, Harry ^c   Dorian, Paul ^d   Kowey, Peter ^e   Le Heuzey, Jean Yves ^f   Merioua, Ihsen ^g   Pedrazzini, Laurence ^g   Prystowsky, Eric N ^h   Schwartz, Peter J ⁱ   Torp Pedersen, Christian ^j   Weintraub, William ^k  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e LANKENAU HOSPITAL   (United States)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g SANOFI   (France)

^h ST VINCENT HOSPITAL   (United States)

ⁱ UNIVERSITY OF PAVIA   (Italy)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k Christiana Center for Outcomes Research   (United States)

more..

Author keywords

atrial fibrillation; rate control; rhythm control

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE;

ADULT; AGE; AGED; ARTIFICIAL HEART PACEMAKER; ASIAN; CARDIOVERSION; CAUCASIAN; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE REGISTRY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART RHYTHM; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; REVIEW; SINUS BRADYCARDIA; SINUS RHYTHM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 79960579602     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.03.034     Document Type: Article

References (22)

1. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
2. S. de Denus, C.A. Sanoski, J. Carlsson, G. Opolski, and S.A. Spinler Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Arch Intern Med 165 2005 258 262 (Pubitemid 40216276)
3. D. Roy, M. Talajic, and S. Nattel Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
4. R.J. Shelton The AFFIRM study: approaches to control rate in atrial fibrillation J Am Coll Cardiol 44 2004 2418 2419 (Pubitemid 39647625)
5. World Health Organization Global burden of coronary heart disease WHO Web site. The Atlas of Heart Disease and Stroke http://www.who.int/cardiovascular- diseases/en/cvd-atlas-13-coronaryHD.pdf Accessed November 2, 2010
6. The Clinical Quality Improvement Network (CQIN) Investigators Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation The Clinical Quality Improvement Network (CQIN) Investigators Can J Cardiol 14 1998 695 702
7. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, and D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934 (Pubitemid 30005032)
8. R.S. Stafford, and D.E. Singer Recent national patterns of warfarin use in atrial fibrillation Circulation 97 1998 1231 1233 (Pubitemid 28169173)
9. R. Nieuwlaat, A. Capucci, and G.Y. Lip Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 2006 3018 3026 (Pubitemid 44963431)
10. J.Y. Le Heuzey, G. Breithardt, and J. Camm The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 2010 687 693
11. R. Nieuwlaat, A. Capucci, and A.J. Camm Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation Eur Heart J 26 2005 2422 2434 (Pubitemid 41552972)
12. S.D. Corley, A.E. Epstein, and J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513 (Pubitemid 38420179)
13. S.H. Hohnloser, H.J. Crijns, and M. van Eickels Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
14. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug J Am Coll Cardiol 42 2003 20 29
15. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906 (Pubitemid 44175743)
16. I.C. Van Gelder, D.G. Wyse, and M.L. Chandler Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies Europace 8 2006 935 942 (Pubitemid 44614202)
17. H.A. Cooper, D.A. Bloomfield, and D.E. Bush Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study) Am J Cardiol 93 2004 1247 1253 (Pubitemid 38607392)
18. I.C. Van Gelder, D.J. Van Veldhuisen, and H.J. Crijns RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure Background, aims, and design of RACE II Am Heart J 152 2006 420 426 (Pubitemid 44233429)
19. K. Fox, I. Ford, P.G. Steg, M. Tendera, and R. Ferrari Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 807 816
20. K. Fox, I. Ford, P.G. Steg, M. Tendera, M. Robertson, and R. Ferrari Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
21. M. Bohm, K. Swedberg, and M. Komajda Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
22. T.R. Betts Is rate more important than rhythm in treating atrial fibrillation? Yes BMJ 339 2009 b3173